Can a herbal remedy boost iron for new moms with anemia?
NCT ID NCT06175117
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a traditional Chinese herbal supplement called Compound E Jiao Jiang to standard iron pills helps women recover from anemia after childbirth. 360 women with mild to moderate anemia were randomly assigned to get either the herbal supplement plus iron or a placebo plus iron for 6 weeks. The main goal was to see if the herbal supplement improved hemoglobin levels more than iron alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
360 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Sep 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients diagnosed with mild or moderate anemia (70g/L≤Hb \< 110g/L) within 1 week postpartum and suitable for oral drug therapy; 2. Age 18-45 years old (including 18 and 45); 3. Those who do not use other iron agents and Chinese medicine/Chinese medicine preparations that have the effect of invigorating qi and nourishing blood during the study; 4. Sign the subject's informed consent voluntarily. Exclusion Criteria: 1. Postpartum hemorrhage and blood transfusion treatment; 2. Those who received intramuscular/intravenous iron therapy or transfused blood products/human blood albumin and other plasma volume dilators within 3 months prior to screening; 3. Patients who have taken blood tonics within 1 week before screening, including other iron preparations and Chinese medicine or Chinese medicine preparations; 4. People with previous blood diseases such as sickle cell anemia, thalassemia, aplastic anemia, megaloblastic anemia; 5. Severe preeclampsia during pregnancy; 6. Abortion occurs in this pregnancy; 7. Patients with a serious digestive disease, cardiovascular disease, immune system disease, or serious mental disorder that the investigator believes may adversely affect the safety of the subject and/or the effectiveness of the investigational drug; 8. Severe hepatic and renal insufficiency (ALT \>2×ULN, aspartate aminotransferase (AST)\>2×ULN, Urea (Urea)/ urea nitrogen (BUN)\>2×ULN, creatinine (Cr)\>1×ULN); 9. Those who have a history of alcohol abuse, drug abuse or drug use before; 10. Allergic to the experimental drug or known ingredient; 11. Participants who had participated in other clinical trials within 3 months before screening; 12. Those who, according to the judgment of the investigator, consider it inappropriate to participate in this clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postpartum anemia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Obstetrics and Gynecology Hospital,Capital Medical UniversityBeijing Maternal and Child Health Care Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.